Invention Grant
- Patent Title: Compounds useful as S100-inhibitors
-
Application No.: US15312762Application Date: 2015-05-22
-
Publication No.: US09771372B2Publication Date: 2017-09-26
- Inventor: Ulf Wellmar , David Liberg , Maria Ekblad , Marie Bainbridge , Stephen East , Jonathan Hargrave , Natacha Prevost
- Applicant: Active Biotech AB
- Applicant Address: SE Lund
- Assignee: Active Biotech AB
- Current Assignee: Active Biotech AB
- Current Assignee Address: SE Lund
- Agency: Renner, Otto, Boisselle & Sklar, LLP
- Priority: EP14169757 20140523
- International Application: PCT/EP2015/061468 WO 20150522
- International Announcement: WO2015/177367 WO 20151126
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
A compound of formula (I) or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.
Public/Granted literature
- US20170204098A1 NOVEL COMPOUNDS USEFUL AS S100-INHIBITORS Public/Granted day:2017-07-20
Information query
